TMCnet News
Research and Markets: China PTCA Balloon Market Investment Report, 2014-2016DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/fnv4xc/china_ptca) has announced the addition of the "China PTCA Balloon Market Investment Report, 2014-2016" report to their offering. PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI (News - Alert)), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore, the development of PTCA balloon industry is closely related to that of PCI. As national economy develops and people's living standard improves, the number of patients receiving PCI has been on the rise year by year, and totaled 454,505 cases in China in 2013, up 16.9% from a year earlier. Demand for PTCA balloon duing the same period reached 1.186 million sets, rising by 13.8% on a year-on-year basis. Despite year-on-year growth in the number of PCI cases in China, the penetration is still very low. In 2013, 309.42 per 1 million were people receiving PCI treatment in China, compared with 1800 cases in the United States, showing a vast space for development of the Chinese PCI market and a bright future for PTCA balloon industry. It is expected that China's demand for PTCA balloon will hit 1.824 million sets by 2016. At present, the Chinese PTCA balloon market is still dominated by foreign companies, such as Medtronic, Abbott, Boston Scientific, Goodman, Terumo, etc. However, local Chinese PTCA balloon companies are improving their competitiveness, with overall market share rising to about 40% in 2013 as opposed to 20% in 2009. Key Topics Covered: 1. Concepts Related to PTCA Balloon Industry 2. Operating Environment of Chinese PTCA Balloon Market 3. Overview of Chinese PTCA Balloon Market 4. Investment in Chinese PTCA Balloon Market 5. Major Chinese Companies 6. Major Foreign Companies
For more information visit http://www.researchandmarkets.com/research/fnv4xc/china_ptca |
